Intended Use

The HeartFlow Analysis is a coronary physiologic simulation software for clinical quantitative and qualitative analysis of previously acquired Computed Tomography DICOM data for clinically stable symptomatic patients with coronary artery disease. It provides calculations of FFRCT, a mathematical quantity computed from simulated pressure, velocity and blood flow information obtained from a 3D computer model generated from static coronary CT images. It supports functional evaluation of coronary artery disease.

Technology

HeartFlow Analysis is a software medical device analyzing CT Coronary Angiography data, performing semi-automated extraction of anatomic data including heart structures, centerline detection, and providing functional simulation by computing FFRCT (Fractional Flow Reserve derived from CT). It generates 3D models of coronary arteries and derives simulated hemodynamic parameters such as blood flow and pressure for clinical use.

Performance

The device underwent design validation including stress testing, repeatability testing, and evaluation using diagnostic images from clinical trials. Preclinical studies from predicates were reviewed, concluding acceptable safety and effectiveness. The testing affirms that the device performs as intended and is safe for clinical use.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    11/12/2020

    1 month
  • 2

    FDA Approval

    1/8/2021

Other devices from HeartFlow, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.